Trial Profile
Assessment of Physician Compliance to Recommended Liver Function Test Monitoring for Tykerb Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2023
Price :
$35
*
At a glance
- Drugs Lapatinib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 02 Nov 2011 New trial record